139 related articles for article (PubMed ID: 16378598)
21. Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways.
Beales IL; Ogunwobi O
Mol Cell Endocrinol; 2006 Mar; 247(1-2):140-9. PubMed ID: 16442704
[TBL] [Abstract][Full Text] [Related]
22. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells.
Hemström TH; Sandström M; Zhivotovsky B
Int J Cancer; 2006 Sep; 119(5):1028-38. PubMed ID: 16570272
[TBL] [Abstract][Full Text] [Related]
24. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells.
Moon DO; Lee KJ; Choi YH; Kim GY
Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321
[TBL] [Abstract][Full Text] [Related]
25. LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway.
Poh TW; Pervaiz S
Cancer Res; 2005 Jul; 65(14):6264-74. PubMed ID: 16024628
[TBL] [Abstract][Full Text] [Related]
26. The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C.
Tenzer A; Zingg D; Rocha S; Hemmings B; Fabbro D; Glanzmann C; Schubiger PA; Bodis S; Pruschy M
Cancer Res; 2001 Nov; 61(22):8203-10. PubMed ID: 11719451
[TBL] [Abstract][Full Text] [Related]
27. [Targeted molecular strategies for cancer therapy based on the blockage of oncogenic pathways in human tumor cells].
Ozaki K
Yakugaku Zasshi; 2007 Jun; 127(6):983-91. PubMed ID: 17541249
[TBL] [Abstract][Full Text] [Related]
28. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
29. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
Curnock AP; Knox KA
Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
[TBL] [Abstract][Full Text] [Related]
30. Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death.
Zhu L; Derijard B; Chakrabandhu K; Wang BS; Chen HZ; Hueber AO
Cancer Lett; 2014 Nov; 354(2):355-64. PubMed ID: 25199763
[TBL] [Abstract][Full Text] [Related]
31. Insulin is a potent survival factor in mesangial cells: role of the PI3-kinase/Akt pathway.
Hiromura K; Monkawa T; Petermann AT; Durvasula RV; Shankland SJ
Kidney Int; 2002 Apr; 61(4):1312-21. PubMed ID: 11918738
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of phosphatidylinositol 3-kinase causes cell death in rat osteoblasts through inactivation of Akt.
Zhang Y; Zhang L; Yan M; Zheng X
Biomed Pharmacother; 2007 Jun; 61(5):277-84. PubMed ID: 17433610
[TBL] [Abstract][Full Text] [Related]
33. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.
Dutton A; Reynolds GM; Dawson CW; Young LS; Murray PG
J Pathol; 2005 Mar; 205(4):498-506. PubMed ID: 15714459
[TBL] [Abstract][Full Text] [Related]
34. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
36. An Involvement of PI3-K/Akt Activation and Inhibition of AIF Translocation in Neuroprotective Effects of Undecylenic Acid (UDA) Against Pro-Apoptotic Factors-Induced Cell Death in Human Neuroblastoma SH-SY5Y Cells.
Jantas D; Piotrowski M; Lason W
J Cell Biochem; 2015 Dec; 116(12):2882-95. PubMed ID: 26012840
[TBL] [Abstract][Full Text] [Related]
37. Cbl participates in shikonin-induced apoptosis by negatively regulating phosphoinositide 3-kinase/protein kinase B signaling.
Qu D; Xu XM; Zhang M; Jiang TS; Zhang Y; Li SQ
Mol Med Rep; 2015 Jul; 12(1):1305-13. PubMed ID: 25815461
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway.
Yu C; Mao X; Li WX
Biochem Biophys Res Commun; 2005 Jun; 331(2):391-7. PubMed ID: 15850772
[TBL] [Abstract][Full Text] [Related]
39. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
[TBL] [Abstract][Full Text] [Related]
40. PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells.
Jeong SJ; Dasgupta A; Jung KJ; Um JH; Burke A; Park HU; Brady JN
Virology; 2008 Jan; 370(2):264-72. PubMed ID: 17931677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
